Cleared Traditional

K232953 - AquaBplus

Also marketed or referenced as:
AquaB LITE

K232953 is an FDA 510(k) clearance for AquaBplus, manufactured by Fresenius Medical Care Renal Therapies Group, LLC. The device is a Class 2 Gastroenterology & Urology device with product code FIP cleared through the Traditional 510(k) pathway after a 266-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2024
Decision
266d
Days
Class 2
Risk

K232953 is an FDA 510(k) clearance for the AquaBplus. Classified as Subsystem, Water Purification (product code FIP), Class II - Special Controls.

Submitted by Fresenius Medical Care Renal Therapies Group, LLC (Waltham, US). The FDA issued a Cleared decision on June 13, 2024 after a review of 266 days - an extended review cycle.

This device falls under the Gastroenterology & Urology FDA review panel, regulated under 21 CFR 876.5665 - the FDA gastroenterology and urology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Gastroenterology & Urology review framework, consistent with the majority of Class II 510(k) submissions.

View all Fresenius Medical Care Renal Therapies Group, LLC devices

FDA 510(k) Submission Details - K232953

510(k) Number K232953 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 21, 2023
Decision Date June 13, 2024
Days to Decision 266 days
Submission Type Traditional
Review Panel Gastroenterology & Urology (GU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
135d slower than avg
Panel avg: 131d · This submission: 266d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FIP Device Classification - Class 2, Special Controls

Product Code FIP Subsystem, Water Purification
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 876.5665
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Gastroenterology & Urology devices follow this clearance model.

Regulatory Peers - FIP Subsystem, Water Purification

All 71
Devices cleared under the same product code (FIP) and FDA review panel - the closest regulatory comparables to K232953.
DIASAFEplusUS (F00013010)
K251851 · Fresenius Medical Care Renal Therapies Group, LLC · Oct 2025
AquaA
K252181 · Fresenius Medical Care North America · Sep 2025
UPT Series Medical RO Water Treatment System
K250514 · Specialty Water Technologies, Inc. · Mar 2025
AQUAbase nX
K223479 · B.Braun Medical, Inc. · Aug 2023
RenaPure Endotoxin Retentive Filter
K231410 · Evoqua Water Technologies, LLC · Jul 2023
AmeriWater MediQA Reverse Osmosis System (MSP3HF)
K223656 · AmeriWater, LLC · Feb 2023